Skip to main content

08 - References

References

906 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 12 References

  1. Rihs M, et al. Caffeine consumption in hospitalized psychiatric patients. Eur Arch Psychiatry Clin Neurosci 1996; 246:83–92.
  2. Clementz GL, et al. Psychotropic effects of caffeine. Am Fam Physician 1988; 37:167–172.
  3. Ogawa N, et al. Clinical importance of caffeine dependence and abuse. Psychiatry Clin Neurosci 2007; 61:263–268.
  4. Desbrow B, et al. An examination of consumer exposure to caffeine from retail coffee outlets. Food Chem Toxicol 2007; 45:1588–1592.
  5. McCusker RR, et al. Caffeine content of decaffeinated coffee. J Anal Toxicol 2006; 30:611–613.
  6. Adolfo AB, et al. Effects of smoking cues on caffeine urges in heavy smokers and caffeine consumers with and without schizophrenia. Schizophr Res 2009; 107:192–197.
  7. Grant JE, et al. Caffeine’s influence on gambling behavior and other types of impulsivity. Addict Behav 2018; 76:156–160.
  8. Sawynok J. Pharmacological rationale for the clinical use of caffeine. Drugs 1995; 49:37–50.
  9. O’Keefe JH, et al. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-­cause mortality. J Am Coll Cardiol 2013; 62:1043–1051.
  10. Pharmaceutical Press. Martindale: The Complete Drug Reference. 2024; www.medicinescomplete.com.
  11. Bergin JE, et al. Common psychiatric disorders and caffeine use, tolerance, and withdrawal: an examination of shared genetic and environmental effects. Twin Res Hum Genet 2012; 15:473–482.
  12. Silverman K, et al. Withdrawal syndrome after the double-­blind cessation of caffeine consumption. N Engl J Med 1992; 327:1109–1114.
  13. Butler MA, et al. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 1992; 2:116–127.
  14. Kaplan GB, et al. Dose-­dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol 1997; 37:693–703.
  15. Pharmaceutical Press. Medicines Complete: Stockley’s Drug Interactions. 2024; www.medicinescomplete.com.
  16. Baethge C, et al. Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients. Bipolar Disord 2009; 11:494–503.
  17. Carrillo JA, et al. Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients. J Clin Psychopharmacol 1998; 18:311–316.
  18. Ohta R, et al. Serotonin syndrome triggered by overuse of caffeine and complicated with neuroleptic malignant syndrome: a case report. Cureus 2022; 14:e22468.
  19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn (DSM-­5). Arlington, VA: American Psychiatric Association; 2013.
  20. Wesnes KA, et al. An evaluation of the cognitive and mood effects of an energy shot over a 6h period in volunteers: a randomized, double-­ blind, placebo controlled, cross-­over study. Appetite 2013; 67:105–113.
  21. Szpak A, et al. A case of acute suicidality following excessive caffeine intake. J Psychopharmacol 2012; 26:1502–1510.
  22. Trapp GS, et al. Energy drink consumption among young Australian adults: associations with alcohol and illicit drug use. Drug Alcohol Depend 2014; 134:30–37.
  23. Pennington N, et al. Energy drinks: a new health hazard for adolescents. J Sch Nurs 2010; 26:352–359.
  24. Sheehan BE, et al. Caffeinated and non-­caffeinated alcohol use and indirect aggression: the impact of self-­regulation. Addict Behav 2016; 58:53–59.
  25. Görgülü Y, et al. A case of acute psychosis following energy drink consumption. Noro Psikiyatri Arsivi 2014; 51:79–81.
  26. Kelsey D, et  al. A case of psychosis and renal failure associated with excessive energy drink consumption. Case Rep Psychiatry 2019; 2019:3954161.
  27. Rodrigues Cordeiro C, et al. Triggers for acute mood episodes in bipolar disorder: a systematic review. J Psychiatr Res 2023; 161:237–260.
  28. Szoke A, et al. Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia – data from the FACE-­SZ cohort. J Psychiatr Res 2023; 161:206–212.
  29. Han Almis B, et al. Is there a relationship between caffeine intake and smoking and positive and negative symptom severity in schizophrenia? Psychiatr Danub 2023; 35:56–61.
  30. Wang HR, et al. Caffeine-­induced psychiatric manifestations: a review. Int Clin Psychopharmacol 2015; 30:179–182.
  31. De Freitas B, et al. Effects of caffeine in chronic psychiatric patients. Am J Psychiatry 1979; 136:1337–1338.
  32. Koczapski A, et al. Effects of caffeine on behavior of schizophrenic inpatients. Schizophr Bull 1989; 15:339–344.
  33. Dratcu L, et al. Clozapine-­resistant psychosis, smoking, and caffeine: managing the neglected effects of substances that our patients consume every day. Am J Ther 2007; 14:314–318.
  34. Achor MB, et al. Diet aids, mania, and affective illness. Am J Psychiatry 1981; 138:392.
  35. Wang L, et al. Coffee and caffeine consumption and depression: a meta-­analysis of observational studies. Aust NZ J Psychiatry 2016; 50:228–242.
  36. Maremmani I, et  al. Are “social drugs” (tobacco, coffee and chocolate) related to the bipolar spectrum? J Affect Disord 2011; 133:227–233.
  37. Lee MA, et al. Anxiogenic effects of caffeine on panic and depressed patients. Am J Psychiatry 1988; 145:632–635.
  38. Rizkallah E, et al. Could the use of energy drinks induce manic or depressive relapse among abstinent substance use disorder patients with comorbid bipolar spectrum disorder? Bipolar Disord 2011; 13:578–580.
  39. Machado-­Vieira R, et al. Mania associated with an energy drink: the possible role of caffeine, taurine, and inositol. Can J Psychiatry 2001; 46:454–455.
  40. Uhde TW, et al. Caffeine-­induced escape from dexamethasone suppression. Arch Gen Psychiatry 1985; 42:737–738.
  41. Cantu TG, et al. Caffeine in electroconvulsive therapy. Ann Pharmacother 1991; 25:1079–1080.

Other substances CHAPTER 12 42. Mester R, et al. Caffeine withdrawal increases lithium blood levels. Biol Psychiatry 1995; 37:348–350. 43. Bruce MS. The anxiogenic effects of caffeine. Postgrad Med J 1990; 66 Suppl 2:S18–S24. 44. Bruce MS, et al. Caffeine abstention in the management of anxiety disorders. Psychol Med 1989; 19:211–214. 45. Santos VA, et al. Panic disorder and chronic caffeine use: a case-­control study. Clin Pract Epidemiol Ment Health 2019; 15:120–125. 46. Klevebrant L, et al. Effects of caffeine on anxiety and panic attacks in patients with panic disorder: a systematic review and meta-­analysis. Gen Hosp Psychiatry 2022; 74:22–31. 47. Ioannidis K, et al. Ostracising caffeine from the pharmacological arsenal for attention-­deficit hyperactivity disorder – was this a correct decision? A literature review. J Psychopharmacol 2014; 28:830–836. 48. Panza F, et al. Coffee, tea, and caffeine consumption and prevention of late-­life cognitive decline and dementia: a systematic review. J Nutr Health Aging 2015; 19:313–328.

No comments to display

Back to top